Roger Stupp
Impact in
- Genetics top 0.01%
- Glioma Diagnosis and Treatment
- Cancer Research top 0.02%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
- Genetics 230
- Glioma Diagnosis and Treatment 222
-
- Brain Metastases and Treatment 90
- Lung Cancer Treatments and Mutations 31
- Co-authors
- Michael WellerMartin J. van den BentThierry GorliaR.O. MirimanoffMonika E. HegiWarren MasonJ. Gregory CairncrossRobert C. Janzer
- Journals
- Journal of Clinical Oncology (59 papers)Neuro-Oncology (41 papers)Annals of Oncology (25 papers)European Journal of Cancer (19 papers)Clinical Cancer Research (13 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Roger Stupp
364 papers receiving 49.0k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Genetics 31.2k
- Cancer Research 10.7k
- Pulmonary and Respiratory Medicine 13.9k
- Radiology, Nuclear Medicine and Imaging 8.2k
- Oncology 9.5k
Countries citing papers authored by Roger Stupp
This map shows the geographic impact of Roger Stupp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Stupp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Stupp more than expected).
Fields of papers citing papers by Roger Stupp
This network shows the impact of papers produced by Roger Stupp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Stupp. The network helps show where Roger Stupp may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roger Stupp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 9 | |
| 4 | 2023 | 8 | |
| 5 | Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment Hit paper breakdown → | 2023 | 148 |
| 6 | 2022 | 13 | |
| 7 | 2021 | 46 | |
| 8 | 2021 | 104 | |
| 9 | 2020 | 21 | |
| 10 | 2020 | 8 | |
| 11 | 2020 | 49 | |
| 12 | 2019 | 124 | |
| 13 | 2018 | 90 | |
| 14 | 2018 | 10 | |
| 15 | 2017 | 144 | |
| 16 | Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial Hit paper breakdown → | 2013 | 742 |
| 17 | 2011 | 28 | |
| 18 | 2010 | 341 | |
| 19 | 2010 | 168 | |
| 20 | 2010 | 68 |
About Roger Stupp
Roger Stupp is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Otorhinolaryngology, having authored 376 papers that have together received 49.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (222 papers), Brain Metastases and Treatment (90 papers), Radiomics and Machine Learning in Medical Imaging (35 papers), Lung Cancer Treatments and Mutations (31 papers), Cancer Treatment and Pharmacology (29 papers), Cancer Genomics and Diagnostics (26 papers), Cancer, Hypoxia, and Metabolism (25 papers) and Meningioma and schwannoma management (23 papers). The work is most often cited by research in Genetics (31.2k citations), Cancer Research (10.7k citations), Pulmonary and Respiratory Medicine (13.9k citations), Radiology, Nuclear Medicine and Imaging (8.2k citations) and Oncology (9.5k citations). Roger Stupp has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Michael Weller, Martin J. van den Bent, Thierry Gorlia, R.O. Mirimanoff, Monika E. Hegi, Warren Mason, J. Gregory Cairncross, Robert C. Janzer, Alba A. Brandes and Denis Lacombe. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Annals of Oncology, European Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.